CD8A and neoplasm: TIGIT ligands are highly expressed in metastatic melanoma and TIGIT and PD-1 blockade increases the proliferation, cytokine production, and degranulation of both tumour antigen-specific CD8+ T cells and CD8+ TILs in the presence of TIGIT ligand-expressing cells.